CompletedNot Applicable

Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model

France1,584 participantsStarted 2022-07-01

Plain-language summary

Management of post-traumatic severe hemorrhage remains a challenge to any trauma care system. Studying integrated and innovative tools designed to predict the risk of early severe hemorrhage (ESH) and resource needs could offer a promising option to improve clinical decisions and then shorten the time of intervention in the context of pre-hospital severe trauma. As evidence seems to be lacking to address this issue, this ambispective validation study proposes to assess on an independent cohort the predictive performance of a newly developed machine learning-based model, as well as the feasibility of its clinical deployment under real-time healthcare conditions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * every severe trauma adult patient to be admitted to a participating center Exclusion Criteria: * patients already diagnosed with active hemorrhage from computed tomography findings; * patients with prior traumatic cardiac arrest * patient under 18 years of age * opposition of patient or relative

What they're measuring

Fβ-score, with β = 4

Timeframe: 18 months

Trial details

NCT IDNCT06270615

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-24

View on ClinicalTrials.gov More Wounds and Injuries trials